Significant dividend increase from 0.12 EUR to 0.20 EUR per share approved
- Dividend yield at 4 %
- Annual general meeting approves all agenda items
Berlin, May 11, 2018: MPH Health Care AG (ISIN: DE000A0L1H32) will continue to benefit from the successful development of its associated companies in the current year. At MPH, this is reflected in the increase in the value of financial investments. In the first quarter of 2018, the associated company generated preliminary net income (IFRS) of EUR 26.75 million (previous year: EUR -2.39 million). Equity rose to EUR 267.42 million (previous year: EUR 211.56 million). Net asset value (NAV) rose year-on-year from EUR 4.94 to EUR 6.25 per share, well above the current share price.
“Our listed investments HAEMATO AG, M1 Kliniken AG and CR Capital Real Estate AG have made a successful start to 2018,” says Patrick Brenske, CEO of MPH. “The healthcare market in Germany has been growing faster than the economy as a whole for years and we are systematically benefiting from this through our investments. With HAEMATO for drugs in the insurance-financed market and with M1 clinics in the private payer market. We are therefore confident that this positive development will continue.”
Due to the sustained positive results of recent years, the Executive Board will propose to the annual general meeting on July 11, 2018 a dividend increase from 12 cents per share to 20 cents per share for the financial year 2017.
The Annual Report 2017 of MPH Health Care AG is available for download at www.mph-ag.de//en/investor-relations